Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies

Identification of MHC class I phospho-peptide antigens from breast cancer utilizing SHLA technology and complementary enrichment strategies

US Patent 11414458 · Granted Aug 16, 2022

Estimated economic value: $14,289,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treatment using BCN057 and BCN5122025
Rapid identification and sequence analysis of intact proteins in complex mixture2025
Rapid identification and sequence analysis of intact proteins in complex mixture2025
Rapid identification and sequence analysis of intact proteins in complex mixture2025
Dumbbell having a threaded connection for adding weight plates2024
Target peptides for immunotherapy and diagnostics2024
Target peptides for immunotherapy and diagnostics2024
Pressure regulator2023
Devices and assays for diagnosis of viral and bacterial infections2023
System and method for developing an application2023
Methods of treating radiation induced gastrointestinal syndrome (RIGS) and relat2022
Rapid identification and sequence analysis of intact proteins in complex mixture2022